Michael Bonney
Vermögen: 6 Mio $ am 31.05.2026
Vermögen: 6 Mio $ am 31.05.2026
Michael W. Bonney ist ein Geschäftsmann, der bereits an der Spitze von 7 verschiedenen Unternehmen stand. Er ist Chairman bei Alnylam Pharmaceuticals, Inc. und Chairman bei Kaleido Biosciences, Inc. sowie Chairman bei Magenta Therapeutics, Inc. Außerdem ist er im Vorstand von Bristol Myers Squibb Co., Life Sciences Cares und X-Biotix Therapeutics, Inc. und Vorsitzender des Bates College. In der Vergangenheit war er Vorsitzender von Rare LLC (Virginia), Director-National Business bei Zeneca Pharmaceuticals, Partner bei Third Rock Ventures LLC, Vice President-Sales & Marketing bei Biogen, Inc, Director bei Cubist Pharmaceuticals LLC, Vorsitzender des Gulf of Maine Research Institute und Director bei Biotechnology Innovation Organization. Herr Bonney erwarb einen Bachelor-Abschluss am Bates College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.08.2025 | 20’804 ( 0.02% ) | 6 Mio $ | 31.05.2026 | |
| 18.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Vorsitzender | 01.04.2024 |
| IMMUNIC, INC. | Vorsitzender | 16.05.2026 |
Life Sciences Cares
Life Sciences Cares Miscellaneous Commercial ServicesCommercial Services Operates organization to eradicate poverty | Direktor/Vorstandsmitglied | - |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 21.04.2020 |
Gulf of Maine Research Institute
Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute that provides collaborative solutions to global ocean challenges | Direktor/Vorstandsmitglied | - |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Develops oral protein degradation therapies | Vorsitzender | 09.01.2023 |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Vorsitzender | 05.01.2023 |
| KALEIDO BIOSCIENCES, INC. | Vorstandsvorsitzender | 21.08.2018 |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 34 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for bone and mineral disorders | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
abrdn Healthcare Investors
abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Life Sciences Investors
abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Healthcare Opportunities Fund
abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
abrdn World Healthcare Fund
abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Bates College
Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whitehead Institute for Biomedical Research
Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Provides research and technology services | Commercial Services |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm targets companies operating in the fields of the healthcare sector. It provides financing for early stage capital requirements. It acts as a lead investor. | Finance |
Gulf of Maine Research Institute
Gulf of Maine Research Institute Miscellaneous Commercial ServicesCommercial Services Operates research institute that provides collaborative solutions to global ocean challenges | Commercial Services |
Pharmaceutical Manufacturers Association of America | |
Zeneca Pharmaceuticals
Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Rare (Virginia)
Rare (Virginia) Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that engages in driving social change for people and nature | Commercial Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Life Sciences Cares
Life Sciences Cares Miscellaneous Commercial ServicesCommercial Services Operates organization to eradicate poverty | Commercial Services |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Autolus Therapeutics Plc
Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Develops oral protein degradation therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen